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Background: Medication-related adverse events have been estimated to be responsible for 5700 deaths and cost
the UK £750 million annually. This burden falls disproportionately on older people. Outcomes from interventions to
optimise medication management are caused by multiple context-sensitive mechanisms. The MEdication
Management in Older people: REalist Approaches BAsed on Literature and Evaluation (MEMORABLE) project uses
realist synthesis to understand how, why, for whom and in what context interventions, to improve medication
management in older people on complex medication regimes residing in the community, work.
Method: This realist synthesis uses secondary data and primary data from interviews to develop the programme
theory. A realist logic of analysis will synthesise data both within and across the two data sources to inform the
design of a complex intervention(s) to help improve medication management in older people.
1. Literature Review
The review (using realist synthesis) contains five stages to develop an initial programme theory to understand
why processes are more or less successful and under which situations: Focussing of the research question;
developing the initial programme theory; developing the search strategy; selection and appraisal based on
relevance and rigour; and data analysis/synthesis to develop and refine the programme theory and context,
intervention, mechanism configurations.
2. Realist Interviews
Realist interviews will explore and refine our understanding of the programme theory developed from the
realist synthesis. Up to 30 older people and their informal carers (15 older people with multi-morbidity, 10
informal carers and 5 older people with dementia), and 20 care staff will be interviewed.
3. Developing framework for the Intervention(s)
Data from the realist synthesis and interviews will be used to develop a framework for the intervention(s) to
identify: the mechanisms that need to be 'triggered', and the contexts related to these mechanisms.
Intervention strategies that change the contexts so the mechanisms are triggered to produce desired
outcomes will be developed. Feedback on these strategies will be obtained.
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Discussion: This realist synthesis aims to develop a framework (underpinned by our programme theory) for a
novel multi-disciplinary, multi-agency intervention(s), to improve medication management in community-
dwelling older people on complex medication regimens.
Systematic review registration: PROSPERO CRD42016043506
Keywords: Medication management, Older people, Patient safety, Primary care health, PolypharmacyBackground
Between 2010 and 2050, the number of older people
living in the UK will nearly double from around 10 to 19
million [1]. Half of people aged 75 or more are living
with two or more long-term conditions [2]. The Francis
report emphasised that patients should be protected
from avoidable harm [3]. Yet, medication-related adverse
events have been estimated to be responsible for 5700
deaths, at a cost of £750 million to the UK health ser-
vice, every year [4]. Furthermore, between 5 and 8% of
unplanned hospital admissions in the UK are related to
medication issues [5].
Safe and effective medication management is particu-
larly challenging in older people with chronic or long-
term conditions on multiple medications with some
degree of frailty and/or cognitive impairment [6–12].
Older people, particularly those with dementia, may be
more susceptible to medication-related adverse events
and less able to identify when a medication error has
taken place [6, 8, 13, 14].
Complex care pathways delivered by a diverse range of
care staff are needed to support medication management
[2, 15]. For instance, older people often attend multiple
clinics and interact with multiple health and social care
professionals including GPs, community pharmacists,
district nurses, and various secondary care clinicians, all
of whom may help to optimise their medication manage-
ment [6, 15]. In addition, for many older people, formal
and informal carers have a key and pivotal role and pro-
vide front-line support for their medication management
needs [16, 17]. However, formal carers frequently lack
the appropriate training to deliver this role and informal
carers, who often have self-care difficulties themselves,
struggle with the responsibility and find the role stressful
and burdensome [17–21]. Recent NICE guidance has
identified the need for a collaborative approach to
supporting older people with long-term conditions in
managing their medication(s) [22].
Realist approaches aim to understand how a given
context affects any mechanism, to generate either a posi-
tive or a negative outcome [23, 24]. In other words, they
explore the relationship between context, mechanism
and outcome (CMO) configurations or CMOCs [23].
Our MEdication Management in Older people: REalist
Approaches BAsed on Literature and Evaluation(MEMORABLE) study uses a realist synthesis to ad-
dress the three steps within the Medical Research
Council framework for Developing Complex Interven-
tions: identifying the evidence base, identifying/devel-
oping theory and modelling process and outcomes
[25]. An additional file shows an overview of the
study in a flow chart (see Additional file 1). Recog-
nised guidelines for ensuring the quality of the review
and how it is reported (the RAMESES guidelines) will
be followed [23]. In this study, the realist programme
theories will be developed through a combination of
secondary (literature review, in the form of a realist
synthesis: work package 1) and primary (realist inter-
views: work package 2) data collection methods. In
work package (WP) 3, we will use data from within
and across WP1 and WP2 to further develop and re-
fine the realist programme theory. The data collected
from each work package will be continually analysed
to enable emerging findings from one package to in-
form the other. Finally, the resulting refined realist
programme theory will be used to design the frame-
work for the intervention(s) (WP3).
Methods/design
Aim
The project aims to use realist synthesis including pri-
mary data collection to develop a framework for a novel
multi-disciplinary, multi-agency intervention(s), to im-
prove medication management in community-dwelling
older people on complex medication regimens.
Objectives
1. To understand how and why any potentially relevant
interventions, to optimise medication management,
work (or do not work) for particular groups of older
people in certain circumstances.
2. To synthesize the findings from objective 1 into a
realist programme theory of an intervention(s) to
support older people living in the community
manage their medication.
3. To use realist programme theory developed from
objective 2 to inform the development of an
intervention(s) to assist older people living in the
community to manage their medication.
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Method
This literature review (in the form of a realist synthesis)
comprises five stages:
1. Focussing the synthesis: the overall focus is to develop
a realist programme theory for an intervention to
support older people living in the community to
manage their medication. The realist synthesis will
be focussed on the most relevant strategies that
would be needed to be used in the medicine
management intervention developed.
2. Developing initial programme theory: a programme
theory sets out how and why outcomes occur within
an intervention [23, 26].
We will iteratively consult with our stakeholder
group, and search the literature to locate current
theories [27]. This searching is more exploratory
than the formal searching in step 3 and aims to
rapidly identify a range of possibly relevant
explanatory theories. Iterative discussions in the
project team will aim to understand and synthesise
the various theories into an initial coherent
programme theory. The stakeholder group (that
includes patient and public involvement) will
provide content expertise to help synthesise the
initial programme theory and later refinement.
The initial programme theory (candidate theory)
will be refined as the synthesis progresses with
input from both the project team and stakeholder
group. The theory will be mapped out as a series of
outcome steps required for the final desired
outcome, identifying intermediate outcomes that
take place either sequentially or in parallel [28]. For
each step (where possible at this stage), the relevant
and associated context and mechanism for each
outcome will be developed from data identified
from our exploratory searches [28, 29].3. Developing a search strategy: we will use a CIMO
(Context, Intervention, Mechanisms, Outcome)
question framework [30] to construct an initial
sampling frame for medication management in older
people. The initial CIMO framework is:
Context: older people living in the community,
medication complexity, ethnicity. Subgroup: people
with dementia living in the community.
Intervention: based on previous work and
literature reviews, possible interventions include
support from formal or informal carers, education,
medication review, self-management and tools
(including technology) to support adherence.
Mechanisms: the mechanism(s) triggered by the
intervention will be identified by the programme
theory.Outcomes: quality of life, adherence, adverse
events, carer burden and economic (care costs
including residential care and hospitalisations).
We will then select distinct subsets of literature
from within the sampling frame with which to test
emerging theory [29, 31]. At this point, we
anticipate that we will be able to use a
comprehensive sampling approach. However, if the
size of the literature proves unmanageable, then we
will employ a variety of appropriate sampling
strategies (e.g. theoretical sampling, maximum
variation sampling, extreme case sampling) to
optimise the analytical value of the realist synthesis
component, as specified by the methodology [32].
The initial sampling frame will be used as the
starting point for selection of ‘index papers’ from
which suggested conceptual or contextual
explanations will be identified, developed and
explored by following links out to wider bodies of
relevant literature [29, 31]. When retrieved data
suggests certain mechanisms may be particularly
important, the search techniques will be refined to
identify data from other clinical environments where
these mechanisms may also be in operation, so that
we can better understand their behaviour under
different contexts.
Realist synthesis uses iterative, purposive sampling
from a wide range of evidence to develop, refine,
confirm and refute theories about how and why an
intervention works, for whom, and in what
circumstances [32]. Consequently, the search
strategy will be developed iteratively and re-visited at
predetermined milestones, using different permuta-
tions and additional concepts [29, 31]. Searching will
be guided by the need to find data to develop the
programme theory; and hence, additional searching
may be needed.
We will subsequently use ‘cluster searching’ to
identify ‘clusters’ of data from related publications.
This approach will add to the conceptual richness
and contextual thickness of studies initially identified
within the sampling frame constructed through
conventional topic-based searching [31]. We will
identify ‘sibling’ (i.e. directly linked outputs from a
single study) and ‘kinship’ (i.e. associated papers with
a shared contextual or conceptual pedigree) papers
and reports to add richness of data while preserving
both rigour and relevance [31]. Active pursuit of
citation networks, using Google Scholar and Web of
Science will be used to link index papers to the
wider literature. Searching will continue until
sufficient data is found (‘theoretical saturation’) to
conclude that a candidate programme theory is
sufficiently coherent and plausible [29].
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literature when devising search strategies relating to
older people or medication management [33]. Based
on previous work, international guidance and
discussions with information specialists, sources will
include Scopus, Web of Science, EMBASE/PubMed/
MEDLINE, Cochrane, CINAHL, PsycINFO,
ProQuest, Sociological Abstracts, Google Scholar,
BASE (Bielefield Academic Search Engine)/ETHOS
(British Library Electronic Thesis Online)/ProQuest
Dissertations and Thesis, Grey Literature in Europe
(http://www.opengrey.eu/) and NHS Evidence and
equivalent, external experts and charities/user
groups, and reference lists of relevant papers [29,
34].
4. Selection and appraisal: inclusion and exclusion are
based on [29, 35]:
 Does the document contain any data that can
contribute to developing or testing theory
(relevance)?
 Are the methods (if any) utilised to generate the
relevant data trustworthy and credible (rigour)?
Selection and appraisal is a two-step process:
1. Potentially relevant documents will initially be
screened by title, abstract and key words [29, 31]
by the Research Associate (RA). A 10% random
sample will be checked by AB and GW for
consistency (any disagreements will be resolved
with the input of IM).
2. The full texts of this set of documents will be
obtained and screened by the RA. Again, a 10%
random sample will be checked by AB and GW
for consistency using the same approach as
outlined above.
The full texts of all relevant documents will be
imported into NVivo (a qualitative data analysis
software tool). Relevant data from included
documents will be coded into NVivo. Some of the
codes will come from the programme theory (i.e.
deductive coding). Others will come from the data
(i.e. inductive coding). These codes will cover
concepts that are judged to be important and
potentially relevant to the programme theory. When
coding, where it is possible to make such inferences,
data will be coded as context, mechanism or
outcome. Any data that informs the relationship of
data within Context-Mechanism-Outcome-Config-
urations (CMOCs) or between the CMOCs
(contained within the programme theory) will also
be coded [23, 35].
5. Data analysis and synthesis: This will configure the
coded data to develop the CMOCs within the
programme theory by piecing together data from
different sources [23]. Relevant data will beinterpreted as being about context, mechanism and/
or outcome within the CMOCs contained within
our overarching programme theory. These data may
come from a range of included documents or from
the interview transcripts (see WP2 below). The
configurations will be presented and discussed and
debated within our regular project team meetings.
We will ask a number of questions about the data
informed by the approach used in Wong et al. (see
Box 1 in the reference [27]). These questions will
cover relevance, interpretation of meaning,
judgement regarding the CMOCs, judgements about
the programme theory and rigour. Part of the
process of data analysis will involve making
inferences about the relationships of the CMOCs to
the programme theory [23]. Where needed, we will
attempt to link our findings to substantive theories
to further refine our theoretical understanding; for
example, social cognitive theory is frequently
referenced in connection with medication self-
management and may help to explain some aspects
of the programme theory [36, 37].
WP2: realist interviews
Realist interviews are a type of qualitative interview
where the researcher does a ‘show and tell’ with the par-
ticipant [38]. Realist studies are not constructivist [39].
Therefore, unlike other qualitative interviewing, in real-
ist interviews, the interviewer starts with some ideas
about (for example) how and why an intervention might
‘work’––informed by their programme theory. They
then direct the interviews in such a way as to ‘test’ the
hypothesis contained within their programme theory
[39]. The participant is initially asked a series of general
questions about the topic area (i.e. is ‘eased in’) and then
questioned in the most neutral way possible about as-
pects of the programme theory. An additional file shows
an outline interview schedule (see Additional file 2).
Realist interviews will gather additional data to confirm,
refute or refine aspects of the programme theory devel-
oped from the literature review work package (WP1)
[40]. The intention is that these interviews will be used
to further develop and refine aspects of the programme
theory that remain unclear based on the analyses of data
from the realist synthesis. Or they may surface
potentially relevant data about aspects of the programme
theory that have not been found in the literature.
Method: Ethical approvals for these interviews includ-
ing any with vulnerable populations will be sought prior
to the start of this WP. Focus groups and/or interviews
with older people, informal carers and care staff will be
recorded and transcribed verbatim. We will ascertain
from the participants whether focus groups or one-to-
one interviews are most appropriate. We are mindful of
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people may prefer a one-to-one interview although some
may find the group environment empowering. Based on
our practical experience, one-to-one interviews are likely
to be needed for care staff.
Sample size: Up to 30 older people and their informal
carers (15 older people with multi-morbidity, 10 infor-
mal carers and 5 older people with dementia) and 20
health and social care staff (including formal carers).
Previous experience indicates that this will generate suf-
ficient data for an in-depth analysis from multiple per-
spectives [41, 42]. However, interviews will stop when
theoretical saturation is reached. The sampling strategy
will be informed by the data collected from WP1 and be
directed by the need to find data relevant to explore and
refine aspects of the programme theory developed in
WP1. Sampling of participants will be as follows:
a. Interviews with older people and informal carers:
Participants will be purposively sampled to ensure
diversity in potentially conceptually relevant
characteristics (for example) including age, ethnicity,
gender, number of co-morbidities, presence of de-
mentia and level of support from carer.
b. One-to-one interviews with health and social care
professionals (including GPs, social workers, formal
carers, nurses, community pharmacists, secondary
care consultants) who support older people in
medication management. Participants will be
purposively sampled to ensure diversity in
potentially conceptually relevant characteristics (for
example) including: locality (rural vs. urban) and the
index of deprivation in the area that they work.
Data analysis: NVivo software will be used to organise
the qualitative data. The process of coding the data from
the transcripts of the interviews/focus groups will be
similar to that outlined above in WP1.
Data coding and analysis will initially be conducted
by the RA. One member of the team (GW) will
independently check 10% of interviews for consistency
in coding. Data analysis will take place after each
interview/focus group and use a realist logic of
analysis. Through discussion and disputation, the
project team will make inferences with respect to
how the programme theory should be further refined
(or not) based on the additional data from the realist
interviews. In other words, asking the question how
and why do these findings inform (if at all) the
programme theory from WP1 and what refinements
(if any) do we need to make to it? As quality control
processes, (a) transcripts will be shared with partici-
pants and feedback elicited as to their veracity, and
(b) a 10% sample of transcripts will be checked forconsistencies in coding, interpretations and inferences
made by GW. Any disagreements will be resolved by
discussion between the RA, GW and IM, with IM
being the final arbiter.WP3: developing the framework for an intervention(s)
The data from the realist synthesis (literature review)
and realist interviews will be used to develop a frame-
work for an intervention(s) to support community-
dwelling older people, including people with demen-
tia, manage their medication. The framework will be
underpinned and informed by our programme theory
and is essentially the result of those programme the-
ories that have been prioritised through the literature
searching and stakeholder consultation and then
brought together to form a coherent explanation for
intervention effectiveness. When designing the inter-
vention, we may need to also use other types of
knowledge that is not explicitly articulated within the
programme theory. For example, our programme the-
ory may inform us about which intervention strat-
egies, we need to use within the intervention, but not
provide enough detail for us to be able to stipulate
who is ideally placed to deliver the strategy or how
often. When we implement the intervention, we may
thus also need to draw on other knowledge (such as
from stakeholders) to be able to ‘fill in’ such a gap.
If needed, at this stage, we will undertake additional
searching and/or interviews to find additional relevant
data to refine the programme theory. However, we
anticipate that by this stage, we will have found enough
data for us to reach theoretical saturation. We will be
able to combine the data from these two sources as we
will be using the same logic of analysis for both the
interview data and that from the realist synthesis [32].
To move from programme theory to intervention(s)
design, we will:
a. Use the data from the realist synthesis and realist
interviews to identify the most important
mechanisms within the programme theory that need
to be ‘triggered’ to get desired outcomes
b. Identify which contexts are related to these ‘key’
mechanisms (i.e. which CMOCs are the mechanisms
found in)
c. Draw on data from the realist synthesis that provides
information of the intervention strategies that can
change the contexts in the relevant ‘key’ CMOCs. In
other words, for this last stage, we will seek
information on which intervention strategies we
might be able to use to change the contexts in such
a way that ‘key’ mechanisms are triggered to
produce desired outcomes [23]. Ultimately, the
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intervention strategies [28, 40, 43].
These strategies will be presented to a project event
involving 30 care staff plus 10 PPI reps to obtain detailed
feedback on our proposed intervention strategies. This
will include discussion on the plausibility, feasibility and
relevance to patients and the NHS. The data from this
event will be analysed and the outputs presented to the
stakeholder group providing information on the required
intervention strategies and thus the framework to
formulate an intervention(s) for future feasibility testing.
Discussion
Medication management in older people on polyphar-
macy is one of the key challenges in modern healthcare.
This project aims to develop a framework for novel
multi-disciplinary, multi-agency intervention(s), to im-
prove medication management in community-dwelling
older people on complex medication regimens. An
additional file reports the study against PRISMA-P
criteria (see Additional file 3). Realist approaches aim to
answer the question; “What works for whom, in what
circumstances, how and why?” We have chosen this
approach because it is ideally suited to explore how and
why a complex social programme involving human
actions and decisions, such as medication management,
may or may not work, and thus to inform the theoretical
development of an intervention(s). As far as we are
aware, this is one of the first studies to utilise realism in
medication management. It is also one of the first pro-
jects to deliberately combine a realist synthesis with
primary data collected from realist interviews to ensure
that sufficient relevant data is found for programme
theory development and ‘testing’. As such, it is
methodologically novel and adds to the literature on the
use of realist-based approaches to inform the develop-
ment of programmes [44] and offers an alternative to
the use of the Theoretical Domains Framework to
explore mediators for behavioural change [45, 46].
We have anticipated a challenge common to many
realist syntheses, namely, that of finding enough data for
programme theory development and testing. To address
this issue, we have deliberately built in the following two
strategies in our project––we have expert and novel
searching expertise in our project team (AB) and will
use realist interviews to gather additional relevant data.
Our main goal is to develop the framework
(underpinned and informed by our programme theory)
for an intervention(s), to improve medication manage-
ment in community-dwelling older people on complex
medication regimens. However, in pursuing this goal, we
will use our interpretative research approaches to make
sense of the issues and challenges in this area. We willidentify what is likely to be effective and conversely,
what is not likely to be effective, in what contexts and
for whom. We believe that our increased understanding
will already yield value to the audiences outlined below,
in advance of moving on to piloting the candidate
intervention, as follows:
1. Outputs for policy, decision makers and clinicians:
our findings may have implications for how current
medication optimisation programmes should be
delivered for community-dwelling older people.
2. Outputs for service users and third sector
organisations: we will develop information on how
to make better use of existing medication
management encounters.
3. Outputs for academics/researchers: the findings from
our research are likely to have relevance to other
national and international researchers planning to
develop similar interventions.
Additional files
Additional file 1: Study flow chart. (DOC 68 kb)
Additional file 2: Interview schedule for realist interviews in WP2.
(DOCX 12 kb)
Additional file 3: Checklist against PRISMA-P criteria. (DOCX 29 kb)
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